Browsing: GLP1

NEW real-world evidence shows that GLP-1 receptor agonists significantly reduce joint pain and inflammation in psoriatic arthritis. Patients living with psoriatic arthritis frequently experience a heavy metabolic disease burden, with concomitant obesity operating as a primary driver of heightened systemic inflammation, severe disease activity, and reduced response to biological therapies. To evaluate the therapeutic potential…

Natural GLP-1 activator brings a differentiated approach to synthetic GLP-1 receptor agonists in the increasingly competitive obesity drug market

As the use of glucagon-like peptide-1 (GLP-1) class obesity treatments such as Wegovy and Mounjaro increases, reports of side effects are drawing attention. A wide range of issues is being reported, from the well-known gastrointestinal problems to hair loss

Weight-loss drugs in the glucagon-like peptide-1 (GLP-1) class, such as Wegovy and Mounjaro, are being analyzed for their impact not only on body weight but also on psychological changes that can influence human relationships

SEATTLE —The use of weight-loss drugs like Ozempic or Wegovy has ballooned over the past few years, with one in eight American adults currently taking a GLP-1 medication for weight loss or to manage conditions such as diabetes or heart disease, according to a poll conducted by KFF. Yet for millions of Medicare beneficiaries, these…

GLP-1 pills will widen access but nutrition remains key – Food and Drink Technology Skip to the contentLatest news Interfood Technology expands slicing line XXX Mints return to Fox’s Masterbrand Nestlé spins out water business to accelerate premium growth Shandy Shack modernises identity McVitie’s unites two iconic brands

As interest in gut-first weight management support grows in 2026, this Hello100 GLP-1 Booster review examines the brand-stated Akkermansia, artichoke-derived inulin, and B-vitamin formula, why its stimulant-free daily approach is attracting wellness-focused buyers, and the pricing, subscription, ingredient, and return-policy details to review before ordering

If you’re on a GLP-1 medication such as semaglutide (Ozempic) or tirzepatide (Mounjaro) for type 2 diabetes, or semaglutide (Wegovy), tirzepatide (Zepbound), or orforglipron (Foundayo) for weight loss, you probably know that your food and beverage choices make a big difference in how well you do on these drugs

Millions of seniors who use GLP-1 drugs for weight loss — or want to try them but can’t afford the cost — may soon get some financial relief

Blockbuster weight-loss drugs are being linked to a rare but upsetting side effect that’s showing up in the shower drain